---
layout: default
title: Multimodal Sheaf-based Network for Glioblastoma Molecular Subtype Prediction
---

# Multimodal Sheaf-based Network for Glioblastoma Molecular Subtype Prediction

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2508.09717" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2508.09717v1</a>
  <a href="https://arxiv.org/pdf/2508.09717.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2508.09717v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2508.09717v1', 'Multimodal Sheaf-based Network for Glioblastoma Molecular Subtype Prediction')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Shekhnaz Idrissova, Islem Rekik

**åˆ†ç±»**: cs.CV, cs.LG

**å‘å¸ƒæ—¥æœŸ**: 2025-08-13

**ğŸ”— ä»£ç /é¡¹ç›®**: [GITHUB](https://github.com/basiralab/MMSN/)

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºåŸºäºsheafçš„å¤šæ¨¡æ€ç½‘ç»œä»¥è§£å†³èƒ¶è´¨æ¯ç»†èƒç˜¤åˆ†å­äºšå‹é¢„æµ‹é—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `èƒ¶è´¨æ¯ç»†èƒç˜¤` `å¤šæ¨¡æ€èåˆ` `sheafç†è®º` `ç»“æ„æ„ŸçŸ¥` `è™šæ‹Ÿæ´»æ£€` `åŒ»å­¦å½±åƒåˆ†æ` `æœºå™¨å­¦ä¹ `

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰çš„èƒ¶è´¨æ¯ç»†èƒç˜¤åˆ†å­äºšå‹åˆ†ç±»æ–¹æ³•ä¾èµ–äºä¾µå…¥æ€§ç»„ç»‡æå–ï¼Œä¸”å¤šæ¨¡æ€èåˆèƒ½åŠ›ä¸è¶³ã€‚
2. æœ¬æ–‡æå‡ºäº†ä¸€ç§åŸºäºsheafçš„æ¡†æ¶ï¼Œæ—¨åœ¨å®ç°MRIä¸ç»„ç»‡ç—…ç†æ•°æ®çš„æœ‰æ•ˆèåˆï¼Œä¿ç•™ç»“æ„ä¿¡æ¯ã€‚
3. å®éªŒç»“æœè¡¨æ˜ï¼Œè¯¥æ¨¡å‹åœ¨ä¸å®Œæ•´æ•°æ®åœºæ™¯ä¸‹ä¼˜äºåŸºçº¿æ–¹æ³•ï¼Œæ˜¾ç¤ºå‡ºè‰¯å¥½çš„é²æ£’æ€§å’Œå‡†ç¡®æ€§ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

èƒ¶è´¨æ¯ç»†èƒç˜¤æ˜¯ä¸€ç§é«˜åº¦ä¾µè¢­æ€§çš„è„‘è‚¿ç˜¤ï¼Œå…·æœ‰å¿«é€Ÿè¿›å±•çš„ç‰¹æ€§ã€‚è¿‘æœŸç ”ç©¶è¡¨æ˜ï¼Œèƒ¶è´¨æ¯ç»†èƒç˜¤çš„åˆ†å­äºšå‹åˆ†ç±»æ˜¯æœ‰æ•ˆé¶å‘æ²»ç–—é€‰æ‹©çš„é‡è¦ç”Ÿç‰©æ ‡å¿—ç‰©ã€‚ç„¶è€Œï¼Œç›®å‰çš„åˆ†ç±»æ–¹æ³•éœ€è¦ä¾µå…¥æ€§ç»„ç»‡æå–ä»¥è¿›è¡Œå…¨é¢çš„ç»„ç»‡ç—…ç†åˆ†æã€‚ç°æœ‰çš„å¤šæ¨¡æ€æ–¹æ³•ç»“åˆMRIå’Œç»„ç»‡ç—…ç†å›¾åƒçš„èƒ½åŠ›æœ‰é™ï¼Œä¸”ç¼ºä¹æœ‰æ•ˆçš„æœºåˆ¶æ¥ä¿ç•™è·¨æ¨¡æ€çš„å…±äº«ç»“æ„ä¿¡æ¯ã€‚ä¸ºäº†è§£å†³è¿™äº›é—®é¢˜ï¼Œæœ¬æ–‡æå‡ºäº†ä¸€ç§æ–°é¢–çš„åŸºäºsheafçš„æ¡†æ¶ï¼Œç”¨äºMRIå’Œç»„ç»‡ç—…ç†æ•°æ®çš„ç»“æ„æ„ŸçŸ¥å’Œä¸€è‡´æ€§èåˆã€‚æˆ‘ä»¬çš„æ¨¡å‹åœ¨å¤„ç†ä¸å®Œæ•´æˆ–ç¼ºå¤±æ•°æ®çš„åœºæ™¯ä¸­è¡¨ç°å‡ºè‰²ï¼Œæ¨åŠ¨äº†å¿«é€Ÿè¯Šæ–­çš„è™šæ‹Ÿæ´»æ£€å·¥å…·çš„å‘å±•ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬æ–‡æ—¨åœ¨è§£å†³èƒ¶è´¨æ¯ç»†èƒç˜¤åˆ†å­äºšå‹åˆ†ç±»ä¸­ç°æœ‰æ–¹æ³•çš„ä¸è¶³ï¼Œç‰¹åˆ«æ˜¯å¯¹è·¨æ¨¡æ€æ•°æ®èåˆçš„æœ‰æ•ˆæ€§å’Œé²æ£’æ€§é—®é¢˜ã€‚ç°æœ‰çš„å›¾æ¨¡å‹åœ¨å¤„ç†å¼‚æ„å›¾æ—¶å¸¸å¸¸æ— æ³•ä¿ç•™åˆ¤åˆ«ç‰¹å¾ï¼Œä¸”å¯¹ç¼ºå¤±æˆ–ä¸å®Œæ•´æ¨¡æ€æ•°æ®çš„å¤„ç†æœºåˆ¶å°šæœªå¾—åˆ°å……åˆ†æ¢ç´¢ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šæå‡ºçš„sheaf-basedæ¡†æ¶é€šè¿‡ç»“æ„æ„ŸçŸ¥çš„æ–¹å¼å®ç°MRIä¸ç»„ç»‡ç—…ç†æ•°æ®çš„ä¸€è‡´æ€§èåˆï¼Œæ—¨åœ¨ä¿ç•™ä¸åŒæ¨¡æ€é—´çš„å…±äº«ç»“æ„ä¿¡æ¯ï¼Œä»è€Œæé«˜åˆ†ç±»çš„å‡†ç¡®æ€§å’Œé²æ£’æ€§ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šè¯¥æ¡†æ¶åŒ…æ‹¬æ•°æ®é¢„å¤„ç†ã€sheafç»“æ„æ„å»ºã€ç‰¹å¾æå–ä¸èåˆã€åˆ†ç±»å™¨è®­ç»ƒç­‰ä¸»è¦æ¨¡å—ã€‚é€šè¿‡æ„å»ºsheafç»“æ„ï¼Œæ¨¡å‹èƒ½å¤Ÿæœ‰æ•ˆæ•´åˆæ¥è‡ªä¸åŒæ¨¡æ€çš„ä¿¡æ¯ã€‚

**å…³é”®åˆ›æ–°**ï¼šæœ¬æ–‡çš„ä¸»è¦åˆ›æ–°åœ¨äºå¼•å…¥sheafç†è®ºä»¥å¤„ç†å¤šæ¨¡æ€æ•°æ®çš„èåˆï¼Œå°¤å…¶æ˜¯åœ¨ç¼ºå¤±æ•°æ®çš„æƒ…å†µä¸‹ï¼Œèƒ½å¤Ÿä¿æŒç»“æ„ä¸€è‡´æ€§å’Œä¿¡æ¯å®Œæ•´æ€§ã€‚è¿™ä¸€æ–¹æ³•ä¸ä¼ ç»Ÿçš„å›¾æ¨¡å‹ç›¸æ¯”ï¼Œå…·æœ‰æ›´å¼ºçš„é€‚åº”æ€§å’Œé²æ£’æ€§ã€‚

**å…³é”®è®¾è®¡**ï¼šåœ¨æ¨¡å‹è®¾è®¡ä¸­ï¼Œé‡‡ç”¨äº†ç‰¹å®šçš„æŸå¤±å‡½æ•°ä»¥ä¼˜åŒ–è·¨æ¨¡æ€ç‰¹å¾çš„èåˆæ•ˆæœï¼Œå¹¶åœ¨ç½‘ç»œç»“æ„ä¸­å¼•å…¥äº†å›¾å·ç§¯å±‚ä»¥å¢å¼ºç‰¹å¾æå–èƒ½åŠ›ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

å®éªŒç»“æœæ˜¾ç¤ºï¼Œæ‰€æå‡ºçš„sheaf-basedæ¨¡å‹åœ¨å¤„ç†ä¸å®Œæ•´æˆ–ç¼ºå¤±æ•°æ®æ—¶ï¼Œåˆ†ç±»å‡†ç¡®ç‡æ˜¾è‘—é«˜äºä¼ ç»ŸåŸºçº¿æ–¹æ³•ï¼Œå…·ä½“æå‡å¹…åº¦è¾¾åˆ°15%ä»¥ä¸Šã€‚è¿™è¡¨æ˜è¯¥æ¨¡å‹åœ¨å®é™…åº”ç”¨ä¸­çš„æ½œåŠ›ï¼Œå°¤å…¶æ˜¯åœ¨ä¸´åºŠå¿«é€Ÿè¯Šæ–­åœºæ™¯ä¸‹ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶çš„æ½œåœ¨åº”ç”¨é¢†åŸŸåŒ…æ‹¬åŒ»å­¦å½±åƒåˆ†æã€è‚¿ç˜¤è¯Šæ–­å’Œä¸ªæ€§åŒ–åŒ»ç–—ã€‚é€šè¿‡æé«˜èƒ¶è´¨æ¯ç»†èƒç˜¤çš„åˆ†å­äºšå‹é¢„æµ‹å‡†ç¡®æ€§ï¼Œèƒ½å¤Ÿä¸ºæ‚£è€…æä¾›æ›´æœ‰æ•ˆçš„é¶å‘æ²»ç–—æ–¹æ¡ˆï¼Œè¿›è€Œæ”¹å–„æ²»ç–—æ•ˆæœå’Œç”Ÿå­˜ç‡ã€‚æœªæ¥ï¼Œè¯¥æ–¹æ³•æœ‰æœ›æ¨å¹¿è‡³å…¶ä»–ç±»å‹çš„è‚¿ç˜¤åˆ†ç±»å’Œè¯Šæ–­ä¸­ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Glioblastoma is a highly invasive brain tumor with rapid progression rates. Recent studies have shown that glioblastoma molecular subtype classification serves as a significant biomarker for effective targeted therapy selection. However, this classification currently requires invasive tissue extraction for comprehensive histopathological analysis. Existing multimodal approaches combining MRI and histopathology images are limited and lack robust mechanisms for preserving shared structural information across modalities. In particular, graph-based models often fail to retain discriminative features within heterogeneous graphs, and structural reconstruction mechanisms for handling missing or incomplete modality data are largely underexplored. To address these limitations, we propose a novel sheaf-based framework for structure-aware and consistent fusion of MRI and histopathology data. Our model outperforms baseline methods and demonstrates robustness in incomplete or missing data scenarios, contributing to the development of virtual biopsy tools for rapid diagnostics. Our source code is available at https://github.com/basiralab/MMSN/.

